877 related articles for article (PubMed ID: 24183997)
21. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis.
Zhou X; Ren Y; Liu A; Jin R; Jiang Q; Huang Y; Kong L; Wang X; Zhang L
Sci Rep; 2014 Dec; 4():7461. PubMed ID: 25514838
[TBL] [Abstract][Full Text] [Related]
22. Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells.
Fu X; Tian J; Zhang L; Chen Y; Hao Q
FEBS Lett; 2012 May; 586(9):1279-86. PubMed ID: 22465665
[TBL] [Abstract][Full Text] [Related]
23. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
[TBL] [Abstract][Full Text] [Related]
24. MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.
Xu X; Jiang X; Chen L; Zhao Y; Huang Z; Zhou H; Shi M
Cancer Biother Radiopharm; 2019 Nov; 34(9):559-565. PubMed ID: 31436472
[No Abstract] [Full Text] [Related]
25. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
Feng B; Wang R; Chen LB
Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675
[TBL] [Abstract][Full Text] [Related]
26. Radiation-induced cell death is independent of the apoptotic signals mediated by death-associated protein kinase in human cervical squamous cell carcinoma cells.
Tanaka T; Bai T; Yukawa K; Umesaki N
Oncol Rep; 2005 Oct; 14(4):949-55. PubMed ID: 16142356
[TBL] [Abstract][Full Text] [Related]
27. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
Wang N; Zhou Y; Zheng L; Li H
Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973
[TBL] [Abstract][Full Text] [Related]
28. miR-34b-3p-mediated regulation of STC2 and FN1 enhances chemosensitivity and inhibits proliferation in cervical cancer.
Jin S; Wang W; Xu X; Yu Z; Feng Z; Xie J; Lv H
Acta Biochim Biophys Sin (Shanghai); 2024 Mar; 56(5):740-752. PubMed ID: 38477044
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway.
Hamano R; Miyata H; Yamasaki M; Kurokawa Y; Hara J; Moon JH; Nakajima K; Takiguchi S; Fujiwara Y; Mori M; Doki Y
Clin Cancer Res; 2011 May; 17(9):3029-38. PubMed ID: 21248297
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-7-5p Promotes Cisplatin Resistance of Cervical Cancer Cells and Modulation of Cellular Energy Homeostasis by Regulating the Expression of the PARP-1 and BCL2 Genes.
Yang F; Guo L; Cao Y; Li S; Li J; Liu M
Med Sci Monit; 2018 Sep; 24():6506-6516. PubMed ID: 30219819
[TBL] [Abstract][Full Text] [Related]
31. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.
Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P
Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127
[TBL] [Abstract][Full Text] [Related]
32. Heat shock protein 70 is involved in malignant behaviors and chemosensitivities to cisplatin in cervical squamous cell carcinoma cells.
Yoshidomi K; Murakami A; Yakabe K; Sueoka K; Nawata S; Sugino N
J Obstet Gynaecol Res; 2014 May; 40(5):1188-96. PubMed ID: 24689999
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation.
Chen W; Wang P; Lu Y; Jin T; Lei X; Liu M; Zhuang P; Liao J; Lin Z; Li B; Peng Y; Pan G; Lv X; Zhang H; Ou Z; Xie S; Lin X; Sun S; Ferrone S; Tannous BA; Ruan Y; Li J; Fan S
Theranostics; 2019; 9(20):5739-5754. PubMed ID: 31534516
[TBL] [Abstract][Full Text] [Related]
34. E10A, an adenovirus-carrying endostatin gene, dramatically increased the tumor drug concentration of metronomic chemotherapy with low-dose cisplatin in a xenograft mouse model for head and neck squamous-cell carcinoma.
Adhim Z; Lin X; Huang W; Morishita N; Nakamura T; Yasui H; Otsuki N; Shigemura K; Fujisawa M; Nibu K; Shirakawa T
Cancer Gene Ther; 2012 Feb; 19(2):144-52. PubMed ID: 22116375
[TBL] [Abstract][Full Text] [Related]
35. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.
Qiu T; Zhou L; Wang T; Xu J; Wang J; Chen W; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
Int J Mol Med; 2013 Sep; 32(3):593-8. PubMed ID: 23856992
[TBL] [Abstract][Full Text] [Related]
36. MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1.
Xie Q; Wang S; Zhao Y; Zhang Z; Qin C; Yang X
Oncotarget; 2017 Mar; 8(13):22003-22013. PubMed ID: 28423543
[TBL] [Abstract][Full Text] [Related]
37. miR-634 Activates the Mitochondrial Apoptosis Pathway and Enhances Chemotherapy-Induced Cytotoxicity.
Fujiwara N; Inoue J; Kawano T; Tanimoto K; Kozaki K; Inazawa J
Cancer Res; 2015 Sep; 75(18):3890-901. PubMed ID: 26216549
[TBL] [Abstract][Full Text] [Related]
38. MiR-218 impairs tumor growth and increases chemo-sensitivity to cisplatin in cervical cancer.
Li J; Ping Z; Ning H
Int J Mol Sci; 2012 Nov; 13(12):16053-64. PubMed ID: 23443110
[TBL] [Abstract][Full Text] [Related]
39. MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2.
Wang T; Ge G; Ding Y; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
Chin Med J (Engl); 2014; 127(12):2357-62. PubMed ID: 24931256
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of cell growth and up-regulation of MAD2 in human oesophageal squamous cell carcinoma after treatment with the Src/Abl inhibitor dasatinib.
Wang L; Guo B; Wang R; Jiang Y; Qin S; Liang S; Zhao Y; Guo W; Li K; Fan X
Clin Sci (Lond); 2012 Jan; 122(1):13-24. PubMed ID: 21751967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
